Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹7,420 Cr₹187 Cr₹199 Cr₹169 Cr₹107 Cr

What is the latest Total Non-Current Liabilities ratio of MANKIND PHARMA ?

The latest Total Non-Current Liabilities ratio of MANKIND PHARMA is ₹7,420 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹7,420 Cr
Mar2024₹187 Cr
Mar2023₹199 Cr
Mar2022₹169 Cr
Mar2021₹107 Cr

How is Total Non-Current Liabilities of MANKIND PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹7,420 Cr
3,860.66
Mar2024 ₹187 Cr
-5.97
Mar2023 ₹199 Cr
18.12
Mar2022 ₹169 Cr
57.15
Mar2021 ₹107 Cr -

Compare Total Non-Current Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹98,746.2 Cr 0.8% -1.5% 0.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,938.0 Cr -0.6% -3.7% 7.3% Stock Analytics
DIVIS LABORATORIES ₹179,361.0 Cr 2.8% 0.7% -0.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹151,385.0 Cr 2.4% 2.1% 40.8% Stock Analytics
CIPLA ₹111,220.0 Cr 0.1% 2.2% -5.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,899.0 Cr 0.5% -1.9% 2.2% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

0.8%

-1.5%

0.3%

SENSEX

-1%

-5%

-9.2%


You may also like the below Video Courses